HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
1-Year Return
33.17%
This Quarter Return
-4.84%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.07B
AUM Growth
-$641M
(-38%)
Cap. Flow
-$550M
Cap. Flow
% of AUM
-51.67%
Top 10 Holdings %
Top 10 Hldgs %
75.23%
Holding
55
New
15
Increased
–
Reduced
5
Closed
9
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$35.9M |
| 2 |
Grab
GRAB
|
$14.3M |
| 3 |
Confluent
CFLT
|
$9.94M |
| 4 |
Micron Technology
MU
|
$9.57M |
| 5 |
Lam Research
LRCX
|
$9M |
Top Sells
| 1 |
Apple
AAPL
|
$267M |
| 2 |
Royalty Pharma
RPRX
|
$147M |
| 3 |
Meta Platforms (Facebook)
META
|
$115M |
| 4 |
Affirm
AFRM
|
$58.3M |
| 5 |
Invesco QQQ Trust
QQQ
|
$36.3M |
Sector Composition
| 1 | Healthcare | 40.23% |
| 2 | Communication Services | 28.34% |
| 3 | Consumer Discretionary | 16.85% |
| 4 | Technology | 11.37% |
| 5 | Industrials | 2.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TSMC
TSM
$1.22T
| $7.75M | 0.73% |
+64,443
| New | +$7.75M |
|
27
Tango Therapeutics
TNGX
$760M
| $7.75M | 0.73% |
708,385
| – | – |
|
28
NVIDIA
NVDA
$4.18T
| $7.74M | 0.73% |
+263,150
| New | +$7.74M |
|
29
Pliant Therapeutics
PLRX
$100M
| $7.59M | 0.71% |
562,379
| – | – |
|
30
Qorvo
QRVO
$8.54B
| $7.35M | 0.69% |
+46,963
| New | +$7.35M |
|
31
Analog Devices
ADI
$121B
| $7.34M | 0.69% |
+41,739
| New | +$7.34M |
|
32
Fulcrum Therapeutics
FULC
$372M
| $7.27M | 0.68% |
410,714
| – | – |
|
33
Sana Biotechnology
SANA
$757M
| $7.26M | 0.68% |
468,749
-694,852
| -60% | -$10.8M |
|
34
ASML
ASML
$296B
| $7.19M | 0.68% |
+9,034
| New | +$7.19M |
|
35
Xilio Therapeutics
XLO
$37.2M
| $6.66M | 0.62% |
+416,059
| New | +$6.66M |
|
|
PRDS
36
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $6.55M | 0.61% |
400,000
| – | – |
|
37
Surrozen
SRZN
$107M
| $5.33M | 0.5% |
55,123
| – | – |
|
38
Pacific Biosciences
PACB
$372M
| $4.69M | 0.44% |
229,144
| – | – |
|
39
Generation Bio
GBIO
$38.9M
| $3.61M | 0.34% |
51,035
| – | – |
|
|
DBTX
40
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $1.53M | 0.14% |
328,798
| – | – |
|
41
Dianthus Therapeutics
DNTH
$794M
| $1.47M | 0.14% |
20,788
| – | – |
|
42
Dyne Therapeutics
DYN
$1.88B
| $1.28M | 0.12% |
107,252
| – | – |
|
43
Seres Therapeutics
MCRB
$165M
| $1.1M | 0.1% |
6,592
| – | – |
|
44
Disc Medicine
IRON
$2.09B
| $728K | 0.07% |
8,333
| – | – |
|
|
DADA
45
DELISTED
Dada Nexus
DADA
| $531K | 0.05% |
+40,338
| New | +$531K |
|
|
46
Surrozen, Inc. Warrant
SRZNW
$71K
| $125K | 0.01% |
108,333
| – | – |
|
|
47
Apple
AAPL
$3.56T
| – | – |
-1,883,445
| Closed | -$267M |
|
48
Amplitude
AMPL
$1.44B
| – | – |
-540
| Closed | -$29K |
|
49
SPDR Gold Trust
GLD
$110B
| – | – |
-91,955
| Closed | -$15.1M |
|
50
iShares Core S&P Mid-Cap ETF
IJH
$101B
| – | – |
-63,415
| Closed | -$3.34M |
|